Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-13-014908
Filing Date
2013-04-01
Accepted
2013-04-01 18:44:43
Documents
1
Period of Report
2013-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2301
  Complete submission text file 0001140361-13-014908.txt   3961
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Issuer) CIK: 0001069308 (see all company filings)

EIN.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6900 LAKE WOODLANDS DRIVE APT 1534 THE WOODLANDS TX 77382
Business Address
Radhakrishnan Karthik (Reporting) CIK: 0001573327 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33004 | Film No.: 13732841